Fibroid Uterus, Leiomyoma, Vitamin D Deficiency
Conditions
Brief summary
Determinate the level of vitamin D in blood, and evaluate the prevalence of deficit and insufficiency among patients with diagnosis of uterine fibroids
Detailed description
A cross-sectional prevalence study will be carried out, taking patients with a diagnosis of uterine fibroid in two hospitals; blood level of vitamin D will be taken to determine the proportion of patients with deficit and insufficiency; In addition, the number, size and type (according to the PALM-COEN classification) of the uterine fibroids in each patient will be analyzed.
Interventions
DIAGNOSTIC_TESTLevel of Vitamin D
3 ml of venous blood will be taken to determine the level of vitamin D
Sponsors
Instituto Mexicano del Seguro Social
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes
Inclusion criteria
* Female * Diagnosis of uterine fibroid
Exclusion criteria
* Female with diagnosis of uterine fibroid under treatment with exogenous vitamine D
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| appointment for intervention | 15 minutes | All patients diagnosed with uterine fibroids who come for consultation, will be explained the protocol and if they agree to be part of it, an informed consent will be given and a 3 ml sample of venous blood will be taken. The sample will be analize in a COBAS 6000 ANALYZER SERIES model c501 (by ROCHE) and the reference levels will be: 1-25 ng/mL - DEFICIT 25 - 30 ng/mL - INSUFFICIENCY \> 30 ng/mL - Normal For this study, the qualitative variables will be expressed as frequencies and percentages (%); the quantitative variables will be expressed in means ± standard deviation. The prevalence of vitamin D deficiency at baseline will be calculated using the formula (total cases observed with vitamin D deficiency / total of patients included) X 100. |
Countries
Mexico
Outcome results
None listed